Zobrazeno 1 - 9
of 9
pro vyhledávání: '"G Y, Melmed"'
Autor:
R Panaccione, E B Collins, G Y Melmed, S Vermeire, S Danese, P D R Higgins, W Zhou, D Ilo, D Sharma, Y Sanchez Gonzalez, S T Wang
Publikováno v:
Journal of Crohn's and Colitis. 16:i037-i041
Background The therapeutic armamentarium to treat adult patients with moderately to severely active ulcerative colitis (UC) continues to evolve. With this rapid innovation, the comparative efficacy and safety of more recent advanced therapies remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eda110baec24c7872aba18d88394db97
https://doi.org/10.1093/ecco-jcc/jjab232.033
https://doi.org/10.1093/ecco-jcc/jjab232.033
Autor:
W Reinisch, J Tran, K Patel, N Borruel, G Y Melmed, L Wegrzyn, G Levy, D Ilo, Y Sanchez Gonzalez, R Panaccione
Publikováno v:
Journal of Crohn's and Colitis. 17:i785-i786
Background Upadacitinib (UPA) and tofacitinib (TOFA) are Janus kinase (JAK) inhibitors approved for the treatment of patients (pts) with moderately to severely active ulcerative colitis (UC), but evidence on their comparative efficacy and safety is l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ae3cf04d1a0209d70c7f92cae64d7cd
https://doi.org/10.1093/ecco-jcc/jjac190.0788
https://doi.org/10.1093/ecco-jcc/jjac190.0788
Autor:
W Reinisch, R Panaccione, M Duijvestein, D Ceballos Santos, G Y Melmed, S Xuan, L Wegrzyn, G Levy, D Ilo, Y Sanchez Gonzalez
Publikováno v:
Journal of Crohn's and Colitis. 17:i672-i673
Background Upadacitinib (UPA), an oral Janus kinase inhibitor, and ustekinumab (UST), a parenteral IL-12/23 inhibitor, are approved therapies for patients (pts) with moderately to severely active Ulcerative Colitis (UC). In the absence of head-to-hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d21830a14a831c3ea0805788ddbadb0a
https://doi.org/10.1093/ecco-jcc/jjac190.0676
https://doi.org/10.1093/ecco-jcc/jjac190.0676
Autor:
B Siegmund, G Y Melmed, P M Irving, A Pai, A Patel, J K Sheffield, F Caldera, B A C Cree, M C Dubinsky
Publikováno v:
Journal of Crohn's and Colitis. 16:i395-i396
Background Patients with ulcerative colitis (UC) and patients with multiple sclerosis (MS) have an elevated risk of developing herpes zoster (HZ), caused by reactivation of latent varicella zoster virus (VZV). Increased incidence of HZ has been repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd47f1a84d9ab0eaa0e26b61ef570f5a
https://doi.org/10.1093/ecco-jcc/jjab232.529
https://doi.org/10.1093/ecco-jcc/jjab232.529
Publikováno v:
Journal of Crohn's and Colitis. 16:i454-i455
Background As part of the IBD-DICE (Determinants, Incidence and Consequences of CS Excess) collaborative research programme, this study examined rates of CS use and excess use in patients with IBD over time and after initial diagnosis. Methods Using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2361aa515782264b9a0409073874d3d8
https://doi.org/10.1093/ecco-jcc/jjab232.615
https://doi.org/10.1093/ecco-jcc/jjab232.615
Autor:
Bonnie B. Dean, G. Y. Melmed, Adam Elfant, William C. Orr, A. S. Harper, Ronnie Fass, D. Aguilar, A. Singh, RB Lynn, R. W. Dubois, H.-T. Yu, M. Tedeschi
Publikováno v:
Alimentary Pharmacology & Therapeutics. 25:487-500
Summary Background Effects of frequent nocturnal symptoms of gastro-oesophageal reflux disease (GERD-FNS) on health-related quality of life (HRQOL) and work productivity are not well documented. Aim To assess symptom severity, production loss, and HR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbe31c5beb7eece3a6e1abf320e12fa0
https://doi.org/10.1111/j.1365-2036.2006.03189.x
https://doi.org/10.1111/j.1365-2036.2006.03189.x
Autor:
R W, Dubois, D, Aguilar, R, Fass, W C, Orr, A B, Elfant, B B, Dean, A S, Harper, H T, Yu, G Y, Melmed, R, Lynn, A, Singh, M, Tedeschi
Publikováno v:
Alimentary pharmacologytherapeutics. 25(4)
Effects of frequent nocturnal symptoms of gastro-oesophageal reflux disease (GERD-FNS) on health-related quality of life (HRQOL) and work productivity are not well documented.To assess symptom severity, production loss, and HRQOL among employed adult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c02c213d219106cb10715014d48817b
https://pubmed.ncbi.nlm.nih.gov/17270005
https://pubmed.ncbi.nlm.nih.gov/17270005
Publikováno v:
Alimentary pharmacologytherapeutics. 19(2)
To rationalize decision making around the use of different non-steroidal anti-inflammatory drug (NSAID) treatment strategies in patients with varying degrees of gastrointestinal and cardiovascular risk.The panel comprised nine physicians (three rheum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8359e4cd52ef67b9fda488bba8fbe5e
https://pubmed.ncbi.nlm.nih.gov/15191515
https://pubmed.ncbi.nlm.nih.gov/15191515
Publikováno v:
The Journal of urology. 166(2)
We investigate the longitudinal recovery of quality of life after radical prostatectomy in men with localized prostate cancer.We assessed the self-reported health related quality of life in 247 men undergoing radical prostatectomy for prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d28a03a61a30912a171c39fa62119b14
https://pubmed.ncbi.nlm.nih.gov/12050540
https://pubmed.ncbi.nlm.nih.gov/12050540